This effect is mediated through both the enteric nervous system and central nervous mechanisms, where GLP-1 receptors are expressed
Up to 10 % of tendon-sheath or joint injections cause transient pain and erythema peaking at 24-48 h, resolving without intervention
Promotes muscle growth and recovery
In the ATTAIN-1 trial of orforglipron, the most common adverse events were nausea (2133% depending on dose), constipation (2129%), diarrhea (2123%), vomiting (1324%), and heartburn
& Notaro, R
20 Systematic reviews: Oral vitamin B 12 replacement for the treatment of pernicious anemia 21 Relevant articles were identified by PubMed search from January 1, 1980 to March 31, 2016, focusing on patients with pernicious anemia